Restorative neurostimulation may improve pain, disability, and quality of life in chronic low back pain. Read more.
During the first quarter of 2026, payers have bolstered both spine devicemakers and practices. Here are five moves to know: Tech coverage 1. UnitedHealthcare will cover Highridge Medical’s vertebral ...
Mainstay Medical Holdings plc today announced that the International Society for the Advancement of Spine Surgery (ISASS) has issued recommendations and coverage criteria for the use of restorative ...
DUBLIN--(BUSINESS WIRE)--Mainstay Medical today announced that the United States Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth ...
Groundbreaking neurostimulation technology offers hope and healing for difficult-to-manage pain. Chronic low back pain, a formidable foe causing disability and soaring healthcare costs, now faces a ...
Low back pain is the biggest musculoskeletal issue affecting the world today. At any given moment, up to 33 percent of the population is dealing with low back pain. It is one of the most common ...
DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc today announced the publication of data from a single center, real-world study with one-year clinical follow-up of patients selected from the ...
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota
DUBLIN, February 04, 2026--(BUSINESS WIRE)--Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results